Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Revue Scientifique Et Technique (International Office of Epizootics)|November 11, 2006
Livestock production systems in developing countries: status, drivers, trendsH Steinfeld, T Wassenaar, S JutziMediators of Inflammation|November 7, 2015
The Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsJonas S Jutzi, Heike L PahlCurrent Hematologic Malignancy Reports|January 8, 2025
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic ImplicationsMifra Faiz, Merle Riedemann, Jonas S Jutzi, et al.World Journal of Urology|September 21, 2014
Initial experiences with the Hemopatch® as a hemostatic agent in zero-ischemia partial nephrectomyF Imkamp, Y Tolkach, M Wolters, et al.World Journal of Urology|December 6, 2018
Surgical treatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approachSebastian Nestler, T Bach, T Herrmann, et al.Aktuelle Urologie|November 18, 2015
[Partial Nephrectomy in cT1 Renal Tumours: Conventional Laparoscopic Partial Nephrectomy Compared with LESS Partial Nephrectomy in SITUS Technique]M Wolters, L Wohlatz, T Neumann, et al.Hemasphere|November 15, 2019
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease CloneJonas S Jutzi, Maria Kleppe, Jennifer Dias, et al.Leukemia|October 23, 2019
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in miceSamuel Vorbach, Albert Gründer, Fengbiao Zhou, et al.Blood|March 10, 2018
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasmsJan C Peeken, Jonas S Jutzi, Julius Wehrle, et al.Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.Pageof 2